Infectious Disease News Current Issue

The following articles appeared in the print edition of Infectious Disease News.

Table of Contents

• College campus outbreaks require timely, effective public health measures
• $2.1 million project investigates how feeding wildlife spreads disease
• Access, resistance to antimicrobials remains worldwide challenge
• Adolescent assault victims often do not receive STI testing, prophylaxis
• Agricultural antibiotic misuse may reduce efficacy of pediatric medicine
• Animal viruses show evidence of HAV’s zoonotic origin
• Cases rise in multistate Salmonella outbreak
• CDC redesigns online tool for foodborne outbreaks
• CDC reports record high chlamydia rate in US
• CDC urges PrEP use, awareness among at-risk groups, providers
• Chinese surveillance detects transmissible colistin resistance gene in livestock, humans
• Chlorhexidine catheter gel dressing reduces microorganisms at insertion, suture sites
• CMS’ hospital-acquired conditions payment policy reduces CLABSIs in some facilities
• Communitywide HIV interventions improve care among illicit drug users
• Concomitant infection rare, treatment failure common in infants with SSTI
• Congenital syphilis rates increase across US
• Cryptococcal antigen screening beneficial among HIV patients initiating ART
• Current TB infection influences hyperglycemia diagnosis
• Elimination of vaccine exemptions serves children's best interests
• Expert panel outlines WHO failures during Ebola crisis, suggests reforms
• FDA approves anthrax vaccine for suspected, confirmed exposure
• FDA approves Fluad as first seasonal adjuvant-containing flu vaccine
• FDA approves Genvoya as first TAF-based HIV regimen
• FDA grants antibiotic fast track designation for community-acquired infections
• FDA releases foodborne illness safety standards for farms, food importers
• Genetically engineered RSV vaccine shows early promise
• Gonorrhea resistance to cephalosporins decreases in US
• HCWs overestimate rate of MRSA colonization
• HIV rates peak before armed conflict
• Infection preventionists report increased preparedness since Ebola outbreak
• Macrolide exposure influences risk for cardiac death, arrhythmia
• MSSA-associated infections, deaths occur more often than MRSA in NICU
• Multistate outbreaks cause more than half of foodborne disease deaths
• Nonhuman primates harbor human-specific astroviruses
• OpenBiome develops FMT pill for recurrent C. difficile infection
• Phase 2 trial to assess chikungunya vaccine candidate
• PrEP protects transgender women from HIV infection
• Rapid POC testing informs more patients of HIV, HBV, HCV status
• Recent deaths, microcephaly cases in Brazil linked to Zika virus infection
• Respiratory virus infections linked to complication in lung transplant recipients
• Social media activity engages general public in ID topics
• Statin therapy reduces influenza vaccine effectiveness
• Switch to Genvoya maintains HIV suppression, increases BMD, renal function
• Toddler with XDR-TB treated into remission
• Turing announces hospital discount for Daraprim, but no price reduction
• Use of antibiotics for acne exceeds guideline recommendations
• Utah hospital warns thousands of patients of possible HCV exposure
• Vaccination eases influenza’s impact on work productivity
• Vaccine-derived poliovirus emerges in Laos
• Worldwide measles vaccination prevents 17.1 million deaths over 15 years
• Parameters for PCPs who treat patients with HCV
• Legionnaires’ disease: Community, travel and health care acquisition Donald Kaye, MD, MACP; Matthew E. Levison, MD, FACP
• Diabetic foot infection incidence declines 52% in 15 years
• FDA's scope reprocessing guidelines most cost-effective for infection prevention
• Malaria retreatment safe, effective against subsequent episodes
• Public awareness of sepsis limited in Sweden
• Soil-transmitted helminth infection increases risk for HPV
• C-EDGE: Grazoprevir/elbasvir benefits HIV/HCV coinfected patients
• Medicaid patients with HCV more often denied DAA therapy
• Researchers develop one-step urine test for screening HCV
• TNF-alpha may predict patient reported mental health outcomes
• Eravacycline’s potential in the pipeline Stephen M. Small, PharmD